This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Ohio State University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations in Liver Cancer Treatment by Congcong Xu
Introduction
Congcong Xu is an accomplished inventor based in Columbus, OH (US). He has made significant contributions to the field of cancer treatment, particularly focusing on innovative methods for targeting liver cancer. His work is characterized by a blend of advanced technology and medical research.
Latest Patents
Congcong Xu holds a patent for an RNA nanoparticle designed for liver cancer treatment. The patent, which is a groundbreaking development, discloses compositions and methods for the targeted treatment of liver cancers using Paclitaxel and miR-122. The composition comprises an RNA nanostructure conjugated to a hepatocyte targeting ligand, paclitaxel, and miR-122, aimed at facilitating intracellular drug delivery to liver cancer cells. The RNA nanoparticle consists of three or more self-assembled synthetic RNA oligonucleotides that form a central core domain, with at least three double-stranded arms arranged around the core domain, extending away from it.
Career Highlights
Congcong Xu is affiliated with The Ohio State University, where he continues to advance his research in the field of cancer treatment. His innovative approach to utilizing RNA nanoparticles showcases his commitment to improving therapeutic options for patients suffering from liver cancer.
Collaborations
Some of his notable coworkers include Peixuan Guo and Satheesh Ellipilli, who have collaborated with him on various research projects aimed at enhancing cancer treatment methodologies.
Conclusion
Congcong Xu's work in developing RNA nanoparticles for liver cancer treatment represents a significant advancement in medical technology. His innovative contributions are paving the way for more effective cancer therapies, ultimately benefiting patients in need.